Showing results (1141-1150 of 1,195) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|July 8, 2024
Survival Analysis Without Sharing of Individual Patient Data by Using a Gaussian CopulaFederico BonofiglioPharmaceutical Statistics|August 14, 2024
Principles for Defining Estimands in Clinical Trials-A ProposalTobias Mütze, James Bell, Stefan Englert, et al.Pharmaceutical Statistics|August 18, 2024
Sample Size Reestimation in Stochastic Curtailment Tests With Time-to-Events Outcome in the Case of Nonproportional Hazards Utilizing Two Weibull Distributions With Unknown Shape ParametersPalash Sharma, Milind A PhadnisPharmaceutical Statistics|June 26, 2024
Do You Want to Stay Single? Considerations on Single-Arm Trials in Drug Development and the Postregulatory SpaceYulia Dyachkova, Cornelia Dunger-Baldauf, Nathalie Barbier, et al.Pharmaceutical Statistics|June 11, 2024
The partnership between statisticians and the Institutional Animal Care and Use Committee (IACUC)David Potter, Thomas Bradstreet, Davit Sargsyan, et al.Pharmaceutical Statistics|May 6, 2024
Visualizing hypothesis tests in survival analysis under anticipated delayed effectsJosé L Jiménez, Isobel Barrott, Francesca Gasperoni, et al.Pharmaceutical Statistics|May 21, 2024
A model-assisted design for partially or completely ordered groupsConnor Celum, Mark ConawayPharmaceutical Statistics|April 16, 2024
Tree-temporal scan statistics for safety signal detection in vaccine clinical trialsFrançois Haguinet, Fabian Tibaldi, Christophe Dessart, et al.Pharmaceutical Statistics|April 17, 2024
Comparing various Bayesian random-effects models for pooling randomized controlled trials with rare eventsMinghong Yao, Yulong Jia, Fan Mei, et al.Pharmaceutical Statistics|November 28, 2025
A Weighted Geometric Average Hazard Ratio Based Sample Size Formula for Non-Proportional Hazards and Its Application to a Smoothed Piecewise Model in Cancer Immunotherapy Trial DesignQingyang Zhang, Zixing Wang, Allen Xue, et al.Pageof 120